As 2024 comes to an end, looking back on this year, "turbulence" has become a keyword for many industries, and the IVD industry is also deeply involved in it. From the ever-changing overseas situation, to the complex domestic economic environment, to the intertwined effects of internal policy adjustments, medical insurance cost control, and significant price fluctuations in the IVD industry, the development trajectory of various segments of the IVD industry in 2024 is full of obstacles.

At the beginning of the year, the peak of respiratory infectious diseases brought a brief moment of glory to many IVD companies, with a surge in business volume and red performance. This also ignited the expectations of companies for annual performance growth, and they were all gearing up to show their strength in this wave of recovery. However, the good times did not last long. Starting from the middle of the year or even earlier in the second quarter, the market situation took a sharp turn for the worse, and the order volume significantly decreased. This decline continued until the end of the year, and many companies not only failed to achieve expected growth, but also found it extremely difficult to maintain their original business scale. It is fortunate to be able to reduce the decline in performance. In such a difficult environment, small IVD raw material factories are facing unprecedented survival pressure. As an important yet relatively fragile link in the IVD industry chain, small raw material factories need to explore practical and feasible ways of survival.

1、 Focus on creating distinctive products

The phenomenon of following the trend in the IVD industry is not uncommon, and from a business perspective, following the trend may not be entirely wrong in some cases. But in the IVD raw material subdivision track, the situation is quite different. At present, raw material research and development is facing many challenges, such as increasing investment costs, from purchasing research and development equipment, hiring professional talents to purchasing experimental materials, each of which requires a large amount of capital investment; The output cycle is getting longer and longer, from the initial creative idea to the successful product development and market launch, which involves multiple stages and consumes a lot of time; The rapid diffusion of technology makes it easy for competitors to imitate and learn from it, making it difficult to protect intellectual property rights; In addition, the implementation of centralized procurement policies has led to a high concentration of market share in the hands of a few large enterprises. These factors work together to continuously increase the development and promotion costs of new products, while the benefits are difficult to guarantee.

In this context, if a small IVD raw material factory blindly follows the trend, pursues a wide range of products, and tries to get a share in various fields, it is likely to fall into difficulties due to scattered resources and limited energy. On the contrary, small factories should concentrate their advantageous resources and focus on the research and production of one or several types of characteristic raw materials, creating fewer but more refined products. It is possible to deeply explore one's own technological advantages or processes in a specific raw material field, forming a differentiated competitive advantage. In terms of enzyme raw material production, if small factories can develop enzyme preparations with higher activity and stronger stability to meet the stringent requirements of specific IVD reagent production, they can occupy a place in the market.

2、 Adhere to quality, price reasonably and make profits

From a business logic perspective, there exists a model of first seizing market share and then seeking profit paths. But for small IVD raw material factories, this model is not applicable. As a key determinant of the quality of IVD reagents, the quality of IVD raw materials directly affects the reliability of downstream diagnostic reagents, which in turn affects clinical diagnostic results and patient health. Therefore, small raw material factories need to always prioritize product quality. However, in the real market, some raw material suppliers are willing to sell their products at extremely low prices in pursuit of so-called market share and sales performance. This behavior may seem like it can increase sales in the short term, but in reality, it can leave behind a disaster.

On the one hand, low-priced sales often overlook many practical investments such as labor costs and research and development costs, and only earn meager book profits. Over time, enterprises will bear a heavy economic burden; On the other hand, in order to maintain a low price strategy, companies are likely to compromise on product quality by reducing the required quality testing steps, using low-quality raw materials, etc., resulting in a significant reduction in product quality. This will not only damage one's own reputation and lose customer trust, but also have an impact on the healthy development of the entire IVD industry. Small IVD raw material factories should rely on the characteristics and quality of their products to win the market and profits. By continuously optimizing production processes and improving product quality, we provide customers with cost-effective raw material products.

3、 Establish a brand and expand cooperation channels

A brand with a good reputation can enable customers to quickly identify and build trust among numerous suppliers. Small factories should focus on shaping their brand image, actively participating in industry exhibitions, academic exchange activities, and other means through advantageous products and services, to convey their technological strength, product features, and quality advantages to the market. In addition to establishing cooperative relationships with traditional IVD reagent manufacturers, we can also actively explore opportunities for cooperation with research institutions, universities, and others. Collaborating with research institutions enables timely access to cutting-edge scientific research achievements and technical support, helping enterprises carry out technological innovation and product upgrades.

In the difficult domestic IVD environment of 2025, IVD raw material small factories can only survive and develop in the fierce market competition by maintaining focus and concentration, creating characteristic products, adhering to the bottom line of quality, reasonable pricing and profitability, actively establishing brand image, and expanding cooperation channels.

Just like Hubei Xindesheng Company, as a supplier of IVD reagent raw materials, we always strictly control the production process to ensure stable and reliable product quality. With technological advantages and reliable quality in the research and production of various IVD reagent raw materials such as biological buffering agents, enzyme preparations, and chromogenic substrates, we have won the trust and support of many customers and established a good brand image in the industry. If you need any raw materials, please feel free to contact Xindesheng at any time!